NIH: National Institutes of Health
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Keep Your Body Healthy
Go to the Home pageGo to the About Nida pageGo to the News & Events pageGo to the Funding pageGo to the Publications page
PhysiciansResearchersParents/TeachersStudents/Young AdultsEn Español Drugs of Abuse & Related Topics
 

 

North Carolina Node


The North Carolina Node is a partnership between Duke University, National Development and Research Institutes, the State of North Carolina and 12 community treatment programs distributed across the State. These programs, which include the major providers of treatment in North Carolina, serve more than 20,000 financially, culturally and ethnically diverse clients located in rural and urban settings. The programs include a therapeutic community, area mental health centers, private outpatient agencies, and regional residential addiction treatment centers. Treatments provided encompass a wide range of therapies, both behavioral and pharmacologic, for families, adolescents, and adults.

 

Regional Research and Training Center

Duke University Medical Center
Box 3516
Durham, North Carolina 27110

Principal Investigator

Robert L. Hubbard, Ph.D., M.B.A.
Professor of Psychiatry
Duke University Medical Center
2218 2B Elder Street
DUMC 3419
Durham, NC 27705
919-863-4600 (Voice)
hubbard@ndri-nc.org

Community Treatment Programs

Duke Addictions Program
Durham, NC

Daymark Recovery Services, Inc.
Salisbury, NC

Freedom House
Chapel Hill, NC

Triangle Residential Options for Substance Abuse Treatment
Durham, NC

Alcohol Drug Services
High Point, NC

STEPONE/NC Partnership
Winston-Salem, NC

Julian Keith ADATC
Black Mountain, NC

Mountain Area Recovery Center
Asheville, NC

Orange, Person and Chatham Area Program
Chapel Hill, NC

Piedmont Behavioral Healthcare
Concord, NC

Coastal Horizons Center, Inc.
Wilmington, NC

SouthLight, Inc.
Raleigh, NC

Walter B. Jones ADATC
Greenville, NC


North Carolina Protocol Involvement

PROTOCOL0003 Suboxone (Buprenorphine/Naloxone) Taper: A Comparison of Two Schedules
PROTOCOL0008 A Baseline for Investigating Diffusion of Innovation
PROTOCOL0009 Smoking Cessation Treatment With Transdermal Nicotine Replacement Therapy In Substance Abuse Rehabilitation Programs
PROTOCOL0010 Buprenorphine/Naloxone-Facilitated Rehabilitation for Heroin Addicted Adolescents/Young Adults
PROTOCOL0011 A Feasibility Study of a Telephone Enhancement Procedure (TELE) to Improve Participation in Continuing Care Activities
PROTOCOL0012 Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatitis C Viral Infection, and Sexually Transmitted Infections in Substance Abuse Treatment Programs
PROTOCOL0013 Motivational Enhancement Therapy (MET) to Improve Treatment Utilization and Outcome in Pregnant Substance Users
PROTOCOL0014 Brief Strategic Family Therapy (BSFT) For Adolescent Drug Abusers
PROTOCOL0016 Patient Feedback: A Performance Improvement Study in Outpatient Addiction Treatment
PROTOCOL0018 Reducing HIV/STD Risk Behaviors: A Research Study for Men in Drug Abuse Treatment
PROTOCOL0019 Reducing HIV/STD Risk Behaviors: A Research Study for Women in Drug Abuse Treatment



 

 



NIDA Home | Site Map | Search | FAQs | Accessibility | Help | Privacy | FOIA (NIH) | Employment | Print Version


National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Wednesday, April 25, 2007. The U.S. government's official web portal